2025
SJR Q2
JCR Q3 · 2,7
100 matched articles
SCIE
Journal detail
Clinical Breast Cancer
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1526820919380666
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,932
- Quartile Q2
- H-Index 88
- Cites/doc 2,72
- Docs (3y) 535
- Cites (3y) 1.507
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,7
- 5Y JIF 3
- JCI 0,55
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Oncology Q2
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,932 | 2,7 | 3 | 0,55 | Q3 | 88 |
| 2024 | Q2 | Q3 | 1,018 | 2,5 | 2,7 | 0,63 | Q3 | 85 |
| 2023 | Q2 | Q2 | 0,942 | 2,9 | 2,8 | 0,67 | Q2 | 85 |
| 2022 | Q2 | Q3 | 0,862 | 3,1 | 3,3 | 0,61 | Q3 | 85 |
| 2021 | Q2 | Q3 | 0,824 | 3,1 | 3,4 | 0,57 | Q3 | 85 |
| 2020 | Q2 | Q3 | 1,078 | 3,2 | 3,4 | 0,58 | Q3 | 85 |
| 2019 | Q2 | Q3 | 1,142 | 2,6 | 2,7 | 0,6 | Q3 | 85 |
| 2018 | — | Q3 | — | 2,8 | 2,8 | 0,57 | Q3 | — |
| 2017 | Q2 | Q3 | 1 | 2,7 | 2,7 | 0,6 | Q3 | 85 |
| 2016 | Q2 | Q3 | 1,115 | 2,8 | 2,8 | — | — | 85 |
| 2015 | Q2 | Q2 | 1,038 | 3,1 | 2,7 | — | — | 85 |
| 2014 | Q2 | Q3 | 1,163 | 2,1 | 2,4 | — | — | 85 |
| 2013 | Q2 | Q3 | 1,135 | 2,6 | 2,5 | — | — | 85 |
| 2012 | Q1 | Q3 | 1,259 | 2,4 | 2,3 | — | — | 85 |
| 2011 | Q2 | Q3 | 1,236 | 2,4 | 2,3 | — | — | 85 |
| 2010 | Q2 | Q2 | 1,145 | 2,8 | — | — | — | 85 |
| 2009 | — | Q3 | — | 2,1 | — | — | — | — |
| 2008 | — | Q3 | — | 2,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 185/333 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q3 | 188/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q2 | 151/322 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 149/241 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q3 | 178/245 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q3 | 174/242 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q3 | 161/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q3 | 131/230 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 135/223 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 118/217 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 97/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 147/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 106/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 104/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 111/196 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 79/185 |
| 2009 | ONCOLOGY | SCIE | Q3 | — | 101/166 |
| 2008 | ONCOLOGY | SCIE | Q3 | — | 77/143 |